About
Combination Vaccine
Areas of Focus
Categories
Vaccine
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
5
As Collaborator
18
Total Enrollment
37,715
By Phase
PHASE4: 5PHASE3: 11NA: 1PHASE1: 1PHASE2: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 21UNKNOWN: 2
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT02868970Collaborator
Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction
PHASE4Completed
2,404 participants
Started: Feb 15, 2017 · Completed: Jul 5, 2021
NCT02759354Lead Sponsor
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
PHASE3Completed
754 participants
Started: Apr 26, 2016 · Completed: Aug 1, 2016
NCT02640118Collaborator
The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
NACompleted
24 participants
Started: Aug 31, 2015 · Completed: Jul 31, 2016
NCT01839188Lead Sponsor
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
PHASE3Completed
385 participants
Started: May 1, 2013 · Completed: Mar 19, 2014
NCT01553279Lead Sponsor
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)
PHASE3Completed
284 participants
Started: Mar 30, 2012 · Completed: Sep 27, 2013
Locations (1)
Headquarters
Leiden, Netherlands
Map
Loading map...